new glp 1 Five Unexpected Uses for GLP-1 Receptor Agonists Retatrutide for weight loss: Study
Description
Yan L, Wang J, Cai X, Liou YC, Shen HM, Hao J, et al
GLP-1 and GIP receptors present in the brain offer a direct target for improved metabolic function [14,15]
"NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsusand Wegovy) as per the approved labels
The oral tablet, which produced up to 12.2% weight loss over just 13 weeks in a phase 2 study, is due to enter phase 3 in the second half of 2026
Thats why Josie offers more than just prescriptions
